Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:2935-2939

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crossley, G. H.
Right arrow Articles by Zmijewski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crossley, G. H.
Right arrow Articles by Zmijewski, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE
Medline Plus Health Information
*Pacemakers and Implantable Defibrillators
*Steroids

(Circulation. 1995;92:2935-2939.)
© 1995 American Heart Association, Inc.


Articles

Steroid Elution Improves the Stimulation Threshold in an Active-Fixation Atrial Permanent Pacing Lead

A Randomized, Controlled Study

George H. Crossley, MD; Jeffrey A. Brinker, MD; Dwight Reynolds, MD; William Spencer, MD; W. Ben Johnson, MD; Howard Hurd, MD; Lisa Tonder; Matt Zmijewski; for the Model 4068 Investigators1

From the Cardiology Section, Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC (G.H.C.); Johns Hopkins University, Baltimore, Md (J.A.B.); The University of Oklahoma, Oklahoma City (D.R.); Baylor College of Medicine, Houston, Tex (W.S.); Mercy Hospital, Des Moines, Iowa (W.B.J.); Washington University, St Louis, Mo (H.H.); and Medtronic Inc, Minneapolis, Minn (L.T., M.Z.).

Background Prior work suggests that the addition of a steroid-eluting reservoir to a passive-fixation permanent pacemaker lead improves the stimulation threshold; however, no large randomized study has addressed this issue. Over the last several years, there has been an increase in enthusiasm for the use of active-fixation permanent pacemaker leads for various reasons in spite of the generally accepted notion that active-fixation leads have higher stimulation thresholds.

Methods and Results This multicenter, randomized, controlled study examined the difference in performance between a standard active-fixation atrial lead (Medtronic model 4058) and a steroid-eluting lead (Medtronic model 4068). Stimulation thresholds were obtained in a four-point strength-duration fashion. Evaluations of sensing and impedance were performed as well. These evaluations were performed at implantation, at weeks 1 through 4, and at weeks 6, 12, 24, and 52. Stimulation thresholds were significantly better in the steroid lead than in the nonsteroid lead at each measurement point from 1 week to 12 months. The mean 1.6-V stimulation threshold at 12 months was 0.19±0.2 ms in the steroid lead and 0.41±0.30 ms in the control lead. No acute peaking was observed with the steroid lead, whereas significant peaking was observed with the control lead. There was no difference in long-term sensing or impedance.

Conclusions Inclusion of a steroid-eluting reservoir in an active-fixation permanent pacing lead improved stimulation thresholds in both the subacute and chronic periods and therefore should extend pulse-generator longevity.


Key Words: pacemakers • electrical stimulation • trials




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. Odim, B. Suckow, B. Saedi, H. Laks, and K. Shannon
Equivalent Performance of Epicardial Versus Endocardial Permanent Pacing in Children: A Single Institution and Manufacturer Experience
Ann. Thorac. Surg., April 1, 2008; 85(4): 1412 - 1416.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Schuchert, M. A. Aydin, C. Israel, G. Gaby, and V. Paul
Atrial pacing and sensing characteristics in heart failure patients undergoing cardiac resynchronization therapy
Europace, January 1, 2005; 7(2): 165 - 169.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Z.I. Harris and M.D. Gammage
Alternative right ventricular pacing sites -- where are we going?
Europace, January 1, 2000; 2(2): 93 - 98.
[PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. C. M. Beaufort-Krol, H. Mulder, D. Nagelkerke, T. W. Waterbolk, and M. Th. E. Bink-Boelkens
COMPARISON OF LONGEVITY, PACING, AND SENSING CHARACTERISTICS OF STEROID-ELUTING EPICARDIAL VERSUS CONVENTIONAL ENDOCARDIAL PACING LEADS IN CHILDREN
J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 523 - 528.
[Abstract] [Full Text] [PDF]